The estimated Net Worth of Kyriazi Theo Melas is at least $977 mil dollars as of 16 February 2023. Mr. Melas owns over 8,750 units of Kaleido Biosciences Inc stock worth over $2 and over the last 21 years he sold KLDO stock worth over $508,755. In addition, he makes $468,031 as Independent Director at Kaleido Biosciences Inc.
Theo has made over 8 trades of the Kaleido Biosciences Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 8,750 units of KLDO stock worth $1 on 16 February 2023.
The largest trade he's ever made was exercising 212,675 units of Kaleido Biosciences Inc stock on 10 June 2004 worth over $3,530,405. On average, Theo trades about 20,463 units every 340 days since 2003. As of 16 February 2023 he still owns at least 15,350 units of Kaleido Biosciences Inc stock.
You can see the complete history of Mr. Melas stock trades at the bottom of the page.
Theo Melas-Kyriazi serves as Independent Director of the Company. Mr. Melas-Kyriazi has served as Chief Financial Officer of Levitronix Technologies Inc. and its predecessor companies since 2006. Levitronix Technologies Inc. manufactures and sells magnetically-levitated pumps primarily to microelectronics and life sciences customers. Mr. Melas-Kyriazi also serves as an Executive Partner at Flagship Pioneering, an innovation enterprise that conceives, creates, resources and grows first-in-category life sciences companies, which he joined in April 2019. Mr. Melas-Kyriazi served as a director at Evelo Biosciences, Inc. a role he has held since February 2017. He also served as a director at Valeant Pharmaceuticals International, Inc from 2003 to 2016. From 1986 to 2004, Mr. Melas-Kyriazi served in a variety of management roles at Thermo Fisher Scientific. Mr. Melas-Kyriazi received his M.B.A. from Harvard Business School.
As the Independent Director of Kaleido Biosciences Inc, the total compensation of Theo Kyriazi at Kaleido Biosciences Inc is $468,031. There are 5 executives at Kaleido Biosciences Inc getting paid more, with Jerald Korn having the highest compensation of $1,505,420.
Theo Kyriazi is 60, he's been the Independent Director of Kaleido Biosciences Inc since 2019. There are 4 older and 12 younger executives at Kaleido Biosciences Inc. The oldest executive at Kaleido Biosciences Inc is Anne Prener, 62, who is the Independent Director.
Kyriazi's mailing address filed with the SEC is C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139.
Over the last 6 years, insiders at Kaleido Biosciences Inc have traded over $0 worth of Kaleido Biosciences Inc stock and bought 3,273,186 units worth $32,952,342 . The most active insiders traders include Ventures Fund Iv General Pa..., Joshua T Brumm, eVentures Fund V General Par.... On average, Kaleido Biosciences Inc executives and independent directors trade stock every 119 days with the average trade being worth of $55. The most recent stock trade was executed by Daniel L Menichella on 8 February 2021, trading 20,000 units of KLDO stock currently worth $230,000.
the next breakthrough microbiome company from flagship venturelabs – the innovation foundry of flagship ventures – is coming.
Kaleido Biosciences Inc executives and other stock owners filed with the SEC include: